References B·R·A·H·M·S PCT
  1. (accessed October 2019).
  2. Muller B, Becker KL, et al., Calcitonin precursors are reliable markers of sepsis in a medical intensive care. Critical care medicine 2000; 28(4): 977-983.
  3. Simon L, Gauvin F, et al., Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and metaanalysis. Clin Infect Dis. 2004; 39: 206-17.
  4. Christ-Crain M. et al., Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia. Am. J. Resp. Crit. Care Med. 2006; 174: 84–93.
  5. Stolz al., Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy. Chest 2007; 131(1): 9-19.
  6. Briel M. et al., Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008; 168(18): 2000-7.
  7. Burkhardt O. et al., Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur. Resp. J. 2010; 36(3): 601-7.
  8., Thermo Scientific, Sepsis marker PCT (accessed October 2019), Marker.
  9., Thermo Scientific, Sepsis marker PCT (accessed October 2019), Guidance.
  10. American College of Chest Physicians/Society of Critical Care Medicine, Consensus Conference, Crit Care Med 1992, 20(6): 864-74.
  11. Singer M, et al., The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). Jama 2016; 315: 801-10.
  12. Levy MM, Fink MP, Marshall JC, et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31: 1250-6.